Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe UI now displays the label 'Find contact information' with a lower-case 'c' and shows a new 'Revision: v3.7.0' tag, replacing the previous 'Find Contact Information' and 'Revision: v3.6.6' text. These are cosmetic updates indicating a new page revision rather than substantive content changes.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.6.5 to v3.6.6, indicating a new iteration of the page. No substantive changes to the study details are implied.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a line '2014 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers. This records NIH funding as part of the study's identifiers.SummaryDifference0.0%

- Check38 days agoChange DetectedA new page revision tag Revision: v3.6.5 was added, and the Plain Language Summary along with the older Revision: v3.6.4 were removed.SummaryDifference0.1%

- Check52 days agoChange DetectedAn update changes the page's revision label from v3.6.3 to v3.6.4, signaling a minor platform update with no visible changes to the study details.SummaryDifference0.0%

- Check74 days agoChange DetectedThe recruitment locations count was updated from 17 to 16. The Haarlem, Netherlands listing and the contact name Caroline Doornebos were removed from the Recruiting section.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.